The global Nasopharyngeal Cancer Treatment Market, valued at US$ 574.3 million in 2022, is projected to grow at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2031, surpassing US$ 1.1 billion by 2031. Nasopharyngeal cancer (NPC), a rare head and neck cancer originating in the nasopharynx, is treated with chemotherapy, radiation therapy, immunotherapy, and surgery. The market is...